Media Summary: Shares of some pharmaceutical companies struggled during lockdown as routine procedures and treatments were postponed. French drugmaker Sanofi is buying U.S. biotech Principia and scooping up a specialist in immune system disorders makes sense ... What's the right cost for a coronavirus therapy? Robert Cyran explains how to use cost, value and ability to assess the roughly ...
Breakingviews Tv Drug Boost - Detailed Analysis & Overview
Shares of some pharmaceutical companies struggled during lockdown as routine procedures and treatments were postponed. French drugmaker Sanofi is buying U.S. biotech Principia and scooping up a specialist in immune system disorders makes sense ... What's the right cost for a coronavirus therapy? Robert Cyran explains how to use cost, value and ability to assess the roughly ... Investors are pouring billions of dollars into loss-making startups like Getir and GoPuff that promise to get ice cream and chips to ... With over 40% of American adults obese, the first truly effective weight-reduction therapies will be giant sellers. However, the ... Six European companies, including Dr. Martens and InPost, have launched floats in 2021. That's unusual as the second quarter is ...
China's trade victory is hard for rivals to swallow. Quick containment of COVID-19 let factories restart quickly, helping it expand its ... America will soon have a COVID-19 vaccine glut but this could be a good problem for the country to have, says Robert Cyran. SoftBank shares have leapt after news of a share swap with Deutsche Telekom that will also net it more than $2 billion. It's largely ... Netflix, Sony and others are mulling commercials in shows and games. Given how ad spending gets hit in a downturn, the timing ... Dealmakers at European banks are losing market share in their home region. Fighting back against American giants like ... Europe's main Coke bottler offered $6.2 billion for its Aussie peer to tap faster-growing markets and expand into other drinks.
